Moderators:
Search This Board: 
Created: 07/02/2021 02:58:53 PM - Followers: 0 - Board type: Free - Posts Today: 0
Connect Biopharma (NASDAQ:CNTB) is now covered by analysts at CICC Research. They set an "outperform" rating and a $27.00 price target on the stock.This represents a 35.2% upside from the current price of $19.97
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#3
Connect Biopharma (NASDAQ:CNTB) was downgraded by analysts at conix 05/05/2022 05:13:59 PM
#2
Dipping some toes in the water here ErnieBilco 05/04/2022 11:31:17 AM
#1
CNTB Chart conix 11/19/2021 10:54:46 PM
Post Subject